Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)
At a glance
Conditions
NCT07425106
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Duke University Medical Center
Durham, North Carolinano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Adam Wax, Ph.D. · PRINCIPAL_INVESTIGATOR · Duke University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of Participants with Acceptable OCT Image Quality as Measured by Low-Cost OCT Deviceduring study procedures (30 minutes)
measured by: ability to see clearly defined and recognizable structures of the retina with the low-cost OCT device.
- RNFL Thicknessduring study procedures (30 minutes)
Thickness of retinal nerve fiber layer, measured in microns
- GCL Thicknessduring study procedures (30 minutes)
Thickness of ganglion cell layer, measured in microns.